GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data
GSK plc (NYSE: GSK) announced headline
Price Over Earnings Overview: GSK
Looking into the current session, GSK Inc. (NYSE:GSK) shares are trading at $35.23, after a 0.44% decrease. Over…
Looking Into GSK’s Recent Short Interest
GSK’s (NYSE:GSK) short percent of float has fallen 16.67% since its last report. The company recently reported that…
Merck’s Latest Drug For Chronic Cough Faces FDA Pushback
A panel of advisors to the Food and Drug Administration (FDA) reportedly expressed concerns about the efficacy of Merck & Company, Inc.'s (NYSE:
Senator’s Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company’s Q3 Results That Set Stock Slide In Motion
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump.
Major Buyout Firms Eye Sanofi’s Consumer Health Division Spinoff Valued Over $20B
Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over $20 billion.
Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CVAC), accusing it of failing to credit Acuitas on patents related to COVID-19 vaccines.
European Drug Regulator Recommends Approval Of GSK’s Bone Marrow Cancer Med
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency adopted a posi
GSK Plc Announces The CHMP Of The EMA Has Adopted A Positive Opinion Recommending Approval Of Momelotinib For The Treatment Of Disease-related Splenomegaly Or Symptoms In Adult Patients With Moderate To Severe Anaemia
GSK plc (NYSE: GSK) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of momelotinib for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with moderate to severe anaemia
CureVac Announces Solid Progress In Phase 2 COVID-19 And Seasonal Flu Clinical Development Programs In Collaboration With GSK
COVID-19 Phase 2 clinical trial fully enrolledStudy compares mono- and bivalent vaccine candidates against licensed comparator COVID-19 vaccineFirst participant dosed in seasonal flu Phase 2 part of combined Phase 1/2